Gravity Diagnostics

Gravity Diagnostics is a fast-growing, privately-held clinical laboratory that has established itself as a significant regional and national player in diagnostic testing. The company leveraged its core toxicology and pharmacogenetics services to achieve rapid scale during the COVID-19 pandemic, processing over 4 million COVID-19 tests. Its value proposition is built on a triad of Care, Compliance, and Confidence, offering comprehensive testing solutions supported by a full-service, in-house billing operation and a strong commitment to client service and community engagement.

Integrated high-throughput clinical laboratory operations platform with in-house billing, emphasizing CAP/CLIA-accredited testing services across toxicology, pharmacogenetics, infectious disease, and routine blood work.

Gravity operates in the highly competitive clinical laboratory services market, competing directly with national giants Quest Diagnostics and Laboratory Corporation of America (LabCorp), regional hospital lab networks, and specialized toxicology or genetics labs. Its differentiation is based on a high-touch service model, compliance rigor, and agile responsiveness rather than scale alone.